Apyx Medical Corporation
NASDAQ:APYX
1.16 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 52.349 | 44.51 | 48.517 | 27.711 | 28.154 | 16.686 | 38.883 | 36.627 | 29.52 | 27.681 | 23.66 | 27.671 | 25.411 | 24.23 | 26.953 | 28.097 | 28.779 | 26.676 | 20.211 | 20.495 | 16.551 | 12.447 | 11.484 | 9.936 | 9.597 | 8.442 | 7.371 | 7.486 | 5.521 |
| Cost of Revenue
| 38.227 | 15.379 | 14.916 | 10.207 | 9.027 | 5.893 | 19.122 | 18.712 | 16.963 | 18.689 | 14.462 | 16.338 | 14.68 | 14.242 | 15.099 | 16.248 | 17.464 | 16.075 | 12.649 | 12.514 | 9.434 | 7.19 | 5.724 | 4.596 | 4.588 | 5.274 | 4.139 | 4.134 | 3.215 |
| Gross Profit
| 14.122 | 29.131 | 33.601 | 17.504 | 19.127 | 10.793 | 19.761 | 17.915 | 12.557 | 8.992 | 9.198 | 11.333 | 10.731 | 9.988 | 11.855 | 11.849 | 11.316 | 10.601 | 7.562 | 7.981 | 7.116 | 5.256 | 5.76 | 5.34 | 5.009 | 3.168 | 3.233 | 3.352 | 2.306 |
| Gross Profit Ratio
| 0.27 | 0.654 | 0.693 | 0.632 | 0.679 | 0.647 | 0.508 | 0.489 | 0.425 | 0.325 | 0.389 | 0.41 | 0.422 | 0.412 | 0.44 | 0.422 | 0.393 | 0.397 | 0.374 | 0.389 | 0.43 | 0.422 | 0.502 | 0.537 | 0.522 | 0.375 | 0.439 | 0.448 | 0.418 |
| Reseach & Development Expenses
| 4.844 | 4.544 | 4.321 | 3.92 | 3.811 | 2.469 | 2.455 | 2.618 | 2.16 | 1.416 | 1.26 | 1.329 | 1.197 | 1.854 | 2.083 | 2.061 | 1.643 | 1.187 | 0.986 | 0.907 | 0.717 | 0.694 | 0.463 | 0.513 | 0.38 | 0.183 | 0.097 | 0.106 | 0.122 |
| General & Administrative Expenses
| 48.866 | 48.149 | 43.728 | 33.667 | 36.228 | 21.183 | 21.047 | 19.089 | 17.383 | 13.425 | 9.964 | 8.958 | 10.302 | 9.6 | 9.057 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| -19.637 | 2.3 | 1.3 | 0.8 | 1.5 | 0.8 | 11.37 | 8.565 | 8.417 | 6.686 | 4.894 | 4.341 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 29.229 | 48.149 | 43.728 | 33.667 | 36.228 | 21.183 | 21.047 | 19.089 | 17.383 | 13.425 | 9.964 | 8.958 | 10.302 | 9.6 | 9.057 | 8.497 | 7.566 | 6.79 | 6.011 | 5.756 | 5.605 | 4.912 | 4.713 | 3.9 | 6.456 | 1.753 | 0 | 1.338 | 1.185 |
| Other Expenses
| 0.622 | 0.509 | -0.373 | 0.479 | -0.382 | -0.203 | -11.37 | -8.565 | -8.417 | -6.686 | -4.894 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0.161 | 0.039 | 0.082 | 0.124 | 0 | 0.397 | 0.321 | 2.152 | 2.796 | 1.427 | 1.218 |
| Operating Expenses
| 34.073 | 52.693 | 48.049 | 37.587 | 40.039 | 23.652 | 23.502 | 21.707 | 19.543 | 14.841 | 11.224 | 10.287 | 11.499 | 11.454 | 11.14 | 10.558 | 9.209 | 7.977 | 7.158 | 6.702 | 6.404 | 5.73 | 5.176 | 4.81 | 7.157 | 4.088 | 2.893 | 2.871 | 2.525 |
| Operating Income
| -19.951 | -23.562 | -14.448 | -20.083 | -20.912 | -13.6 | -5.265 | -3.792 | -6.986 | -5.849 | -3.666 | 1.046 | -0.018 | -2.752 | 0.715 | 1.291 | 2.107 | 2.624 | 0.404 | 1.279 | 0.712 | -0.474 | 0.584 | 0.53 | -2.148 | -0.92 | 0.34 | 0.48 | -0.22 |
| Operating Income Ratio
| -0.381 | -0.529 | -0.298 | -0.725 | -0.743 | -0.815 | -0.135 | -0.104 | -0.237 | -0.211 | -0.155 | 0.038 | -0.001 | -0.114 | 0.027 | 0.046 | 0.073 | 0.098 | 0.02 | 0.062 | 0.043 | -0.038 | 0.051 | 0.053 | -0.224 | -0.109 | 0.046 | 0.064 | -0.04 |
| Total Other Income Expenses Net
| -1.331 | 0.651 | -0.372 | 0.674 | 1.002 | -0.924 | -1.341 | 0.064 | 1.799 | -7.285 | -2.482 | 0.02 | 0.287 | -0.773 | -0.052 | 1.496 | 0.14 | 0.087 | -0.161 | -0.039 | -0.082 | -0.122 | 0.05 | 0.009 | 0.003 | 0.022 | 0.034 | 0.011 | 0.057 |
| Income Before Tax
| -21.282 | -22.911 | -14.82 | -19.409 | -19.91 | -13.271 | -5.218 | -3.886 | -5.345 | -13.285 | -5.952 | 0.834 | 0.032 | -2.462 | 0.663 | 2.777 | 2.247 | 2.711 | 0.428 | 1.267 | 0.681 | -0.515 | 0.201 | 0.539 | -2.145 | -0.998 | 0.099 | 0.416 | -0.154 |
| Income Before Tax Ratio
| -0.407 | -0.515 | -0.305 | -0.7 | -0.707 | -0.795 | -0.134 | -0.106 | -0.181 | -0.48 | -0.252 | 0.03 | 0.001 | -0.102 | 0.025 | 0.099 | 0.078 | 0.102 | 0.021 | 0.062 | 0.041 | -0.041 | 0.017 | 0.054 | -0.223 | -0.118 | 0.013 | 0.056 | -0.028 |
| Income Tax Expense
| -2.432 | 0.367 | 0.38 | -7.503 | -0.26 | -3.777 | -0.156 | 0.064 | 0.025 | 3.997 | -1.613 | 0.217 | -0.077 | -0.927 | 0.067 | 0.945 | -0.149 | 0.048 | 0.032 | -0.273 | 0.031 | 0.041 | -0.211 | 0.029 | 0.036 | 0.078 | 0.24 | 0.008 | -0.065 |
| Net Income
| -18.713 | -23.278 | -15.2 | -11.906 | -19.65 | 64.009 | -5.062 | -3.95 | -5.37 | -17.282 | -4.339 | 0.617 | 0.109 | -1.535 | 0.596 | 1.832 | 2.401 | 2.683 | 0.406 | 1.512 | 0.681 | -0.515 | 0.784 | 0.501 | -2.184 | -0.998 | 0.099 | 0.407 | -0.154 |
| Net Income Ratio
| -0.357 | -0.523 | -0.313 | -0.43 | -0.698 | 3.836 | -0.13 | -0.108 | -0.182 | -0.624 | -0.183 | 0.022 | 0.004 | -0.063 | 0.022 | 0.065 | 0.083 | 0.101 | 0.02 | 0.074 | 0.041 | -0.041 | 0.068 | 0.05 | -0.228 | -0.118 | 0.013 | 0.054 | -0.028 |
| EPS
| -0.54 | -0.67 | -0.44 | -0.35 | -0.58 | 1.93 | -0.16 | -0.14 | -0.22 | -0.98 | -0.25 | 0.04 | 0.01 | -0.088 | 0.04 | 0.11 | 0.15 | 0.19 | 0.03 | 0.11 | 0.05 | -0.039 | 0.06 | 0.04 | -0.16 | -0.072 | 0.012 | 0.05 | -0.035 |
| EPS Diluted
| -0.54 | -0.67 | -0.44 | -0.35 | -0.58 | 1.86 | -0.16 | -0.14 | -0.19 | -0.97 | -0.25 | 0.03 | 0.01 | -0.088 | 0.03 | 0.11 | 0.13 | 0.16 | 0.03 | 0.09 | 0.05 | -0.036 | 0.06 | 0.04 | -0.16 | -0.072 | 0.012 | 0.05 | -0.035 |
| EBITDA
| -19.259 | -22.896 | -14.81 | -19.363 | -19.902 | -13.062 | -3.741 | -3.792 | -6.986 | -5.849 | -2.406 | 1.903 | 0.919 | 0.313 | 1.789 | 0.769 | 2.877 | 3.153 | 0.95 | 1.674 | 1.109 | -0.077 | 1.058 | 0.918 | -1.83 | -0.155 | 0.616 | 0.73 | -0.106 |
| EBITDA Ratio
| -0.368 | -0.514 | -0.305 | -0.699 | -0.707 | -0.783 | -0.096 | -0.104 | -0.237 | -0.211 | -0.102 | 0.069 | 0.036 | 0.013 | 0.066 | 0.027 | 0.1 | 0.118 | 0.047 | 0.082 | 0.067 | -0.006 | 0.092 | 0.092 | -0.191 | -0.018 | 0.084 | 0.098 | -0.019 |